Mode
Text Size
Log in / Sign up
N/A N=82 Randomized Triple-blind Treatment

Postoperative Hip Bracing After Hip Arthroscopy

Femoroacetabular Impingement Syndrome · Acetabular Labral Tear

Enrolled (actual)
82
Serious AEs
0.0%
Results posted
May 2025
Primary outcome: Primary: Patient Numerical Pain Ranking Scale (NPRS) — 1.8; 2.3 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Hip brace (Device)
Age
Pediatric, Adult · 14+ yrs
Sex
All
Sponsor
University of Washington
Primary completion
Dec 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Patient Numerical Pain Ranking Scale (NPRS)
1.8; 2.3
SECONDARY
HOOS - Hip Disability and Osteoarthritis Outcome Score
73.9; 71.6; 83.4; 80.8
SECONDARY
VR12 - Veteran RAND 12 Item Health Survey
53.1; 49.0; 38.2; 37.1; 52.2; 51.1
SECONDARY
Patient Using Topical Non-steroidal Medication
1; 3; 1; 2
SECONDARY
Patient Received Cortisone Injection to Hip Flexor Sheath or Bursa
0; 0; 4; 0
SECONDARY
Patient Using Opioid Medication
2; 1; 1; 0
SECONDARY
NPRS - Numerical Pain Ranking Scale
1.6; 1.9

Summary

Hip arthroscopy for treatment of femoroacetabular impingement syndrome (FAIS) involves reshaping of the osseous sources of impingement ("osteoplasty") and treatment of impingement-associated labral tears with labral repair. Postoperative hip braces are advocated to decrease postoperative pain by offloading hip musculature. However there are no studies looking at efficacy of hip braces after hip arthroscopy, and on average 50% of high-volume hip arthroscopists use bracing. The objective of this study is to use a randomized controlled trial to test the cited benefits of postoperative hip bracing on short term patient reported pain scores, validated hip-specific pain scores, and physical exam findings of hip flexor tendonitis.

Eligibility Criteria

Inclusion Criteria

  • Patient age 14-60 on date of surgery
  • Patient seen at the institution for the study
  • Patient scheduled to undergo arthroscopic osteoplasty and labral repair for femoroacetabular impingement syndrome.

Exclusion Criteria

  • Any patient anyone who cannot follow up in person in clinic for the 6-week postoperative visit.
  • Non-English speaking patients (due to limited validation of the patient reported outcome measures in non-English speaking populations).
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04599296). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search